+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanomedicine Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • The Business Research Company
  • ID: 5766720
Nanomedicine involves the application of nanotechnology in the field of medicine. It encompasses substances with sizes ranging from 1 to 100 nanometers, designed to precisely target tumor cells or critical immune cells. Nanomedicine serves as a crucial tool for personalized, targeted, and regenerative medicine, facilitating the delivery of enhanced new drugs, treatments, and implantable devices to both clinicians and patients.

The primary types of nanomedicine include nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles, specifically ultrafine particles typically between 1 and 100 nanometers in diameter, are commonly used in the production of medicines and drugs. Nanomedicine operates across different modalities such as diagnostics and treatments, finding applications in clinical oncology, infectious diseases, clinical cardiology, orthopedics, and other medical fields.

The nanomedicine market research report is one of a series of new reports that provides nanomedicine market statistics, including nanomedicine industry global market size, regional shares, competitors with a nanomedicine market share, detailed nanomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. This nanomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nanomedicine market size has grown rapidly in recent years. It will grow from $292.72 billion in 2023 to $335.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth observed in the historical period can be attributed to factors such as an increased understanding of molecular biology, a growing incidence of chronic diseases, the demand for targeted drug delivery systems, the expansion of nanoparticle imaging technologies, and a rising aging population.

The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $594.63 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The anticipated growth in the forecast period can be attributed to the ongoing expansion of nanotechnology research, increased investments in nanomedicine research and development, a growing focus on personalized medicine, the broadening applications of nanomedicine in cancer treatment, and the integration of nanomedicine in infectious disease therapeutics. Major trends expected in the forecast period include the development of multifunctional nanoparticles for therapeutics and imaging, an emphasis on nanoparticle-based diagnostics and imaging agents, the application of nanomedicine in regenerative medicine, a growing use of nanomedicine in targeted therapy for neurological disorders, and increased collaboration and partnerships in nanomedicine research and commercialization.

The anticipated increase in the prevalence of complex and chronic diseases worldwide is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is becoming increasingly integral in treating chronic conditions such as cardiovascular disorders, diabetes, cancer, and dementia, facilitating the rapid metabolism of drugs within the body. Notably, Alzheimer's Disease International reports that over 50 million people globally suffer from dementia, a number projected to double every 20 years, reaching 80 million by 2030 and 152 million by 2050. The global cancer burden is also predicted to escalate to 28.4 million new cases in 2040. The escalating burden of chronic diseases is poised to drive demand for effective therapeutic treatments based on nanomedicine, thereby fostering the growth of the nanomedicine market.

The growing demand for personalized medicine is expected to propel the nanomedicine market's growth. Personalized medicine, an innovative approach tailoring medical decisions and interventions to individual patients, holds the promise of improving outcomes and treatment efficacy through cutting-edge technology. Reports from October 2022 indicate more than 75,000 genetic testing products and 300 personalized medicines. This increasing demand for personalized medicine is a key driver behind the growth of the nanomedicine market.

Major players in the nanomedicine market are concentrating on innovative products, such as the dynapro zetastar, to enhance their market presence. This advanced instrument enables simultaneous measurements of dynamic and static light scattering, as well as dynamic and electrophoretic light scattering (DLS/SLS/ELS). For instance, Waters Corporation, a US-based analytical laboratory instruments and equipment company, launched the dynapro zetastar for nanoparticle analysis in September 2023. The instrument aids in the precise development of complex biologics by combining multiple light scattering techniques, offering adaptive data capture, automatic data quality assessment, and increased sensitivity and speed of measurements while using minimal sample volumes. The unique flow cell design allows connection to an autosampler, significantly enhancing laboratory productivity and efficiency by enabling unattended measurements for extended periods.

Innovative technologies, such as optical technology, are being employed by major companies in the nanomedicine market to drive revenues. Corning Incorporated, a US-based technology company, introduced corning videodrop in September 2023 - an optical technique measuring the size and concentration of nanoparticles using interferometric microscopy. Videodrop is reliable, quick, and easy to use, with a label-free sample preparation process. The user-friendly software interface ensures smooth operation, and the method allows the quantification of concentration and size distribution without labeling. Viral vectors, including lentivirus, retrovirus, adenovirus, and extracellular vesicles (EVs), within the diameter range of 80-500 nanometers, can be physically titrated using this approach. The Videodrop technique serves as an effective in-process control during the purification process.

In August 2021, Sanofi S. A., a France-based pharmaceutical and healthcare company, acquired Translate Bio, Inc., for $3.2 billion. This strategic move accelerates Sanofi's ongoing vaccination programs, enhances the mRNA Center of Excellence, and enables exploration of additional therapeutic fields. Translate Bio, Inc., a US-based biopharmaceutical company, brings valuable mRNA technology and expertise, advancing Sanofi's research capabilities in this promising technology for developing vaccines and treatments. The acquisition strengthens Sanofi's position in the rapidly evolving field of mRNA technology, allowing exploration of potential game-changing drugs for various conditions.

Major companies operating in the in the nanomedicine market report are Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanomix Crop., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc., Sigma-Aldrich Co. LLC

North America was the largest region in the nanomedicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Nanomedicine Market Characteristics3. Nanomedicine Market Trends And Strategies
4. Nanomedicine Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Nanomedicine Market Size and Growth
5.1. Global Nanomedicine Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Nanomedicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Nanomedicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Nanomedicine Market Segmentation
6.1. Global Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Other Types
6.2. Global Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diagnostics
Treatments
6.3. Global Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinical Oncology
Infectious Diseases
Clinical Cardiology
Orthopedics
Other Applications
7. Nanomedicine Market Regional And Country Analysis
7.1. Global Nanomedicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Nanomedicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Nanomedicine Market
8.1. Asia-Pacific Nanomedicine Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Nanomedicine Market
9.1. China Nanomedicine Market Overview
9.2. China Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Nanomedicine Market
10.1. India Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Nanomedicine Market
11.1. Japan Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Nanomedicine Market
12.1. Australia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Nanomedicine Market
13.1. Indonesia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Nanomedicine Market
14.1. South Korea Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Nanomedicine Market
15.1. Western Europe Nanomedicine Market Overview
15.2. Western Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Nanomedicine Market
16.1. UK Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Nanomedicine Market
17.1. Germany Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Nanomedicine Market
18.5. France Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Nanomedicine Market
19.9. Italy Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Nanomedicine Market
20.13. Spain Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Nanomedicine Market
21.1. Eastern Europe Nanomedicine Market Overview
21.2. Eastern Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Nanomedicine Market
22.1. Russia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Nanomedicine Market
23.1. North America Nanomedicine Market Overview
23.2. North America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Nanomedicine Market
24.1. USA Nanomedicine Market Overview
24.2. USA Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Nanomedicine Market
25.1. Canada Nanomedicine Market Overview
25.2. Canada Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Nanomedicine Market
26.1. South America Nanomedicine Market Overview
26.2. South America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Nanomedicine Market
27.1. Brazil Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Nanomedicine Market
28.1. Middle East Nanomedicine Market Overview
28.2. Middle East Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Nanomedicine Market
29.1. Africa Nanomedicine Market Overview
29.2. Africa Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Nanomedicine Market Competitive Landscape And Company Profiles
30.1. Nanomedicine Market Competitive Landscape
30.2. Nanomedicine Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Ablynx NV
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Amgen Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Arrowhead Research Inc.
30.2. 4.1. Overview
30.2. 4.2. Products and Services
30.2. 4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Bio-Gate AG
30.2. 5.1. Overview
30.2. 5.2. Products and Services
30.2. 5.3. Strategy
30.2.5.4. Financial Performance
31. Global Nanomedicine Market Competitive Benchmarking32. Global Nanomedicine Market Competitive Dashboard33. Key Mergers And Acquisitions In The Nanomedicine Market
34. Nanomedicine Market Future Outlook and Potential Analysis
34.1 Nanomedicine Market In 2028 - Countries Offering Most New Opportunities
34.2 Nanomedicine Market In 2028 - Segments Offering Most New Opportunities
34.3. Nanomedicine Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Executive Summary

Nanomedicine Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nanomedicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for nanomedicine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

  • Markets Covered: 1) By Type: Nanoparticles; Nanoshells; Nanotubes; Nanodevices; Other Types 2) By Modality: Diagnostics; Treatments 3) By Application: Clinical Oncology; Infectious Diseases; Clinical Cardiology; Orthopedics; Other Applications
  • Companies Mentioned: Pfizer Inc.; Ablynx NV; Amgen Inc.; Arrowhead Research Inc.; Bio-Gate AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer Inc.
  • Ablynx NV
  • Amgen Inc.
  • Arrowhead Research Inc.
  • Bio-Gate AG
  • Celgene Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Gilead Sciences Inc.
  • Merck AG
  • Nanospectra Biosciences
  • Nanotherapeutics Inc.
  • NanoViricides Inc
  • Novartis AG
  • Sanofi S. A.
  • Abraxis Bioscience Inc.
  • Alnylam Pharmaceuticals Inc.
  • Arrowhead Pharmaceuticals Inc.
  • AuraSense Therapeutics LLC
  • BIND Therapeutics Inc.
  • Camurus AB
  • Cerulean Pharma Inc.
  • CytImmune Sciences
  • Fujifilm Holdings
  • Nanobiosym Inc.
  • Nanobiotix SA
  • Nanogen Inc.
  • Nanomix Crop.
  • Nanoparticle BioChem Inc.
  • Nanospective Inc.
  • Nanosphere Health Sciences Inc.
  • Nanosys Inc.
  • PerkinElmer Inc.
  • Selecta Biosciences Inc.
  • Sigma-Aldrich Co. LLC

Methodology

Loading
LOADING...